Background Image
Previous Page  67 / 142 Next Page
Information
Show Menu
Previous Page 67 / 142 Next Page
Page Background

Promoting Agricultural Value Chains:

In the OIC Member Countries

58

The lack of adequate political support in terms of R&D, extension and agricultural innovation

thus threatens the long-term viability of agricultural production and limits opportunities to

improve production efficiency and product quality over the short and medium term to

increase the value added by producers.

OIC Member Countries also lag behind when it comes to the adoption of GM crops compared to

other regions of the world. Thus far, only 8 out of 57 OIC Member Countries have

commercialised the use of biotechnology in agriculture (see

Table 4-3)

. In particular, Malaysia

has recently been at the forefront in the adoption of biotechnology with the proclaimed goal of

establishing itself as a biotech player at the global level.

Table 4-3 Commercialisation of GM crops in OIC Member Countries

Country

GM crops

Bangladesh

Eggplant (1

event/variety)

Burkina

Faso

Cotton (1 event/variety)

Egypt

Maize (1 event/variety)

Indonesia

Maize (7

events/varieties)

Sugarcane (3

events/varieties)

Soybean (2

events/varieties)

Iran

3

Rice (1 event/variety)

Malaysia

Carnation (8

events/varieties)

Maize (8

events/varieties)

Soybean (6

events/varieties)

Pakistan

Cotton (2

events/varieties)

Sudan

Cotton (1 event/variety)

Source: ISAAA GM Approval Database, 2015

The reasons for the slow adoption of GM crops can be found in the lack of trained scientists,

inadequate biosafety frameworks and weak political support. Debates and public concerns

about the Halal status of GM crops also play an important role. As many OIC countries are net

importers of food, political leadership in many OIC countries has recently recognised the

importance of biotechnology to meet food demands and promote economic growth. A high

level meeting in the context of the OIC in 2011 established a general political agreement that

biotechnology should be promoted by establishing regulatory frameworks and enabling

infrastructure for the application and commercialisation of biotechnology (Stephensons &

Arujanan, 2011).

3

Iran approved GM rice commercialisation in 2004 but then put a halt on cultivation when the government changed. Only in

the past two years has the Iranian Government been working on establishing a legal framework to facilitate the

commercialisation of GM crops. In June 2015, Iran announced that it had developed its first GM cotton variety.